The perspectives of intra-articular therapy in the management of osteoarthritis

被引：39

作者：

Migliore, Alberto ^{[1
]}

Paoletta, Marco ^{[2
]}

Moretti, Antimo ^{[2
]}

Liguori, Sara ^{[2
]}

Iolascon, Giovanni ^{[2
]}

机构：

[1] S Pietro FBF Hosp, Rheumatol Unit, Rome, Italy

[2] Univ Campania Luigi Vanvitelli, Dept Med & Surg Specialties & Dent, Naples, Italy

来源：

EXPERT OPINION ON DRUG DELIVERY | 2020年 / 17卷 / 09期

关键词：

Osteoarthritis; hyaluronic acid; corticosteroid injection; mesenchymal stem cells; cartilage regeneration; viscosupplementation; intra-articular injection; PLATELET-RICH PLASMA; LANDMARK-GUIDED INJECTIONS; WEIGHT HYALURONIC-ACID; KNEE OSTEOARTHRITIS; CORTICOSTEROID INJECTION; CARTILAGE DEGENERATION; RHEUMATOID-ARTHRITIS; ULTRASOUND GUIDANCE; HIP-OSTEOARTHRITIS; COST-EFFECTIVENESS;

D O I：

10.1080/17425247.2020.1783234

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Introduction Management of Osteoarthritis (OA) still is a challenge for clinicians. Taking into account a multidisciplinary approach including pharmacological and non-pharmacological treatments, intra-articular (IA) injection could be considered as an effective local therapy. Areas covered This review provides a new perspective of IA treatment going beyond current available IA agents. We describe novel biological targets for developing new IA agents and innovative modalities of delivery systems. Additional topics include predictors of response for a better choice of IA agents for each patient, diagnostic and prognostic role of biomarkers, accuracy of IA injection, and cost-effectiveness of IA injection. Expert opinion IA treatments seem to be very promising for the management of OA. Identifying clinical and biochemical predictive factors could drive clinician to the appropriate therapeutic approach. To date, there is a gap regarding the benefit of IA treatments in the 'real practice' once they have been adopted. However, considering these promising effects of IA approach, several open questions remain not clarified.

引用

页码：1213 / 1225

页数：13

共 116 条

[1] Efficacy and safety profile of a compound composed of platelet-rich plasma and hyaluronic acid in the treatment for knee osteoarthritis (preliminary results) [J].

Abate M. ;

Verna S. ;

Schiavone C. ;

Di Gregorio P. ;

Salini V. .

European Journal of Orthopaedic Surgery & Traumatology, 2015, 25 (8) :1321-1326

[2] Review of the Mechanism of Action for Supartz FX in Knee Osteoarthritis [J].

Altman, Roy D. ;

Dasa, Vinod ;

Takeuchi, Jun .

CARTILAGE, 2018, 9 (01) :11-20

[3] Analysis for Prognostic Factors from a Database for the Intra-Articular Hyaluronic Acid (Euflexxa) Treatment for Osteoarthritis of the Knee [J].

Altman, Roy D. ;

Farrokhyar, Forough ;

Fierlinger, Anke ;

Niazi, Faizan ;

Rosen, Jeffrey .

CARTILAGE, 2016, 7 (03) :229-237

[4] Ultrasound-guided shoulder girdle injections are more accurate and more effective than landmark-guided injections: a systematic review and meta-analysis [J].

Aly, Abdel-Rahman ;

Rajasekaran, Sathish ;

Ashworth, Nigel .

BRITISH JOURNAL OF SPORTS MEDICINE, 2015, 49 (16) :1042-1049

[5]

[Anonymous], 2014, Osteoarthritis: Care and Management in Adults

[6] A randomised controlled trial of tidal irrigation vs corticosteroid injection in knee osteoarthritis: the KIVIS Study [J].

Arden, N. K. ;

Reading, I. C. ;

Jordan, K. M. ;

Thomas, L. ;

Platten, H. ;

Hassan, A. ;

Ledingham, J. .

OSTEOARTHRITIS AND CARTILAGE, 2008, 16 (06) :733-739

[7] Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis [J].

Ayhan, Egemen ;

Kesmezacar, Hayrettin ;

Akgun, Isik .

WORLD JOURNAL OF ORTHOPEDICS, 2014, 5 (03) :351-361

[8] OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis [J].

Bannuru, R. R. ;

Osani, M. C. ;

Vaysbrot, E. E. ;

Arden, N. K. ;

Bennell, K. ;

Bierma-Zeinstra, S. M. A. ;

Kraus, V. B. ;

Lohmander, L. S. ;

Abbott, J. H. ;

Bhandari, M. ;

Blanco, F. J. ;

Espinosa, R. ;

Haugen, I. K. ;

Lin, J. ;

Mandl, L. A. ;

Moilanen, E. ;

Nakamura, N. ;

Snyder-Mackler, L. ;

Trojian, T. ;

Underwood, M. ;

McAlindon, T. E. .

OSTEOARTHRITIS AND CARTILAGE, 2019, 27 (11) :1578-1589

[9] A New Class of Potent Matrix Metalloproteinase 13 Inhibitors for Potential Treatment of Osteoarthritis Evidence of Histologic and Clinical Efficacy Without Musculoskeletal Toxicity in Rat Models [J].

Baragi, Vijaykumar M. ;

Becher, Gabriel ;

Bendele, Alison M. ;

Biesinger, Ralf ;

Bluhm, Harald ;

Boer, Juergen ;

Deng, Hongbo ;

Dodd, Rory ;

Essers, Michael ;

Feuerstein, Tim ;

Gallagher, Brian M., Jr. ;

Gege, Christian ;

Hochguertel, Matthias ;

Hofmann, Michael ;

Jaworski, Andreas ;

Jin, Lixia ;

Kiely, Andrew ;

Korniski, Brian ;

Kroth, Heiko ;

Nix, Darrell ;

Nolte, Bert ;

Piecha, Dorothea ;

Powers, Timothy S. ;

Richter, Frank ;

Schneider, Matthias ;

Steeneck, Christoph ;

Sucholeiki, Irving ;

Taveras, Arthur ;

Timmermann, Andreas ;

Van Veldhuizen, Joshua ;

Weik, Juergen ;

Wu, Xinyuan ;

Xia, Bing .

ARTHRITIS AND RHEUMATISM, 2009, 60 (07) :2008-2018

[10] Classification of osteoarthritis biomarkers:: a proposed approach [J].

Bauer, D. C. ;

Hunter, D. J. ;

Abramson, S. B. ;

Attur, M. ;

Corr, M. ;

Felson, D. ;

Heinegard, D. ;

Jordan, J. M. ;

Kepler, T. B. ;

Lane, N. E. ;

Saxne, T. ;

Tyree, B. ;

Kraus, V. B. .

OSTEOARTHRITIS AND CARTILAGE, 2006, 14 (08) :723-727

← 1 2 3 4 5 6 7 8 9 10 →